Excellent
Fully Aligned
Patient Risk:
Low
Summary
The AI response (PASS verdict) accurately states that SYNJARDY/SYNJARDY XR contain a boxed warning for metformin-associated lactic acidosis and that the label provides supporting details and recommended actions, with no contradictions identified.
Category Scores
Accurate Statements
The claim “WARNING: LACTIC ACIDOSIS” is supported because the FDA label includes a boxed warning for metformin-associated lactic acidosis (including fatal cases), with clinical presentation, risk factors, and actions if suspected (immediate discontinuation; prompt hemodialysis recommended).
BOX Lactic Acidosis; Warnings and Precautions (5.1) Lactic Acidosis
The label also includes a dedicated Warnings and Precautions section (5.1) describing metformin-associated lactic acidosis in detail, including risk factors and management steps.
Warnings and Precautions (5.1) Lactic Acidosis
Unsupported Statements
Contradictions
Important Omissions
No specific contraindication language was evaluated in the response (e.g., contraindication for acute/chronic metabolic acidosis including DKA), though it is not required to assess the narrow claim “WARNING: LACTIC ACIDOSIS.”
Importance:
Low
Safety Assessment
Potential Patient Risk:
Low
The evaluated claim is accurately supported by the boxed warning and label warnings section; no incorrect safety guidance was introduced.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Fully Aligned
Primary Issue
Suggested Improvement